At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 40 enrolled
Drug / intervention
ACCU-D1 +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A RANDOMIZED, DOUBLE-BLIND, VEHICLE CONTROLLED, PROOF-OF CONCEPT STUDY OF THE SAFETY AND EFFICACY OF ACU-D1 OINTMENT IN SUBJECTS WITH ACNE ROSACEA
In Brief
A Phase 2 clinical trial evaluating ACCU-D1 and Vehicle for Acne Rosacea. Completed, enrolled 40 participants across 2 sites.
Detailed Summary
The study evaluated the safety, tolerability, and efficacy of ACCU-D1 when applied twice daily for 12 weeks in adult participants with moderate to severe acne rosacea. Two-third of the participants received ACCU-D1 while one-third of the participants received vehicle control.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAcne Rosacea
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
2017201820192020202120222023202420252026
First PostedFeb 2017
Enrollment StartNov 2017
Primary CompletionJun 2018
Study CompletionJun 2018
TodayJul 2026
First PostedFeb 27, 2017
Enrollment StartNov 28, 2017
Primary CompletionJun 5, 2018
Study CompletionJun 18, 2018
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 9.3 years ago
Interventions
ACCU-D1drug
ACCU-D1
Vehicledrug
Placebo Comparator